Company Filing History:
Years Active: 1999
Title: Innovations of James Arthur Gainor
Introduction
James Arthur Gainor, an accomplished inventor based in Collegeville, PA, holds a patent that explores the realm of biochemistry and peptide technology. His work aims to improve the methods of immobilizing peptides on solid supports, contributing to advancements in drug development and biotechnological applications.
Latest Patents
Gainor's noteworthy patent involves the use of N-terminal-marked peptides immobilized on glass beads, specifically targeting controlled-pore glass beads. The innovative method he developed utilizes a C-terminal .alpha.-carboxyl-.omega.-amino linker and an .alpha.-silyl-.omega.-amino anchor. This approach enhances the stability and functionality of peptides, which is critical for various research and pharmaceutical applications.
Career Highlights
Currently associated with Sanofi Pharmaceuticals, Inc., Gainor has honed his skills in the field of peptide chemistry. His patent represents a significant contribution to the pharmaceutical industry, showcasing his dedication to innovative research that can lead to improved therapeutic outcomes.
Collaborations
In his professional journey, Gainor has collaborated with notable colleagues such as Barry Arnold Morgan and Mark A Ator. These partnerships reflect a strong collective effort in advancing scientific research and innovation within the organization.
Conclusion
James Arthur Gainor stands out as a prominent figure in the field of peptide technology, and his contributions through his patent signify a step forward in biochemistry. His work at Sanofi Pharmaceuticals, alongside esteemed collaborators, embodies the spirit of innovation that drives the industry forward.